Features

Ask The Experts

Biosimilars in Rheumatology

What role will biosimilars play in clinical practice?

Latest Features

Fibromyalgia The Role of Neurogenic Inflammation in Fibromyalgia Pathophysiology

The Role of Neurogenic Inflammation in Fibromyalgia Pathophysiology

Geoffrey Littlejohn, MD, provides a clinical perspective on the pathophysiology of fibromyalgia and the role of neurogenic inflammation in the disease process.

Osteoporosis Treating Osteoporotic Pain: Expert Interview

Treating Osteoporotic Pain: Expert Interview

Pain resulting from osteoporotic fractures should be treated with a multimodal approach that includes pharmacological and nonpharmacological strategies.

Rheumatoid Arthritis Advisor Managing Cardiovascular Risk in Rheumatoid Cachexia

Managing Cardiovascular Risk in Rheumatoid Cachexia

Because of the increased risk for cardiovascular disease in patients with rheumatoid arthritis, the increase in fat mass caused by rheumatoid cachexia can be especially concerning.

Spondyloarthritis Gender Differences in Axial Spondyloarthritis: Comparing Disease Burden and Treatment

Gender Differences in Axial Spondyloarthritis: Comparing Disease Burden and Treatment

An improved understanding of the gender differences in axial spondyloarthritis can improve disease treatment and reduce disease burden.

Osteoarthritis Expert Q&A: A Clinical Update on the Prevention, Treatment of Periprosthetic Joint Infections

Expert Q&A: A Clinical Update on the Prevention, Treatment of Periprosthetic Joint Infections

Alberto V. Carli, MD, and Ashley E. Levack, MD, MAS, discuss preventive and treatment options for periprosthetic joint infections.

Rheumatoid Arthritis Advisor Examining the Obesity Paradox in Patients With Rheumatoid Arthritis

Examining the Obesity Paradox in Patients With Rheumatoid Arthritis

Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.

Biosimilar Drugs Nonmedical Switching in Rheumatic Disease: An Interview With Allan Gibofsky, MD

Nonmedical Switching in Rheumatic Disease: An Interview With Allan Gibofsky, MD

Allan Gibofsky, MD, shares insight on the cost associated with nonmedical switching in patients with rheumatic diseases.

Practice Management Should Physicians Treat Family and Friends? Three Experts Weigh In

Should Physicians Treat Family and Friends? Three Experts Weigh In

Several notable medical societies have issued ethical statements discouraging physicians from treating family members and friends.

Spondyloarthritis Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic Characteristics

Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic Characteristics

It is unclear whether ankylosing spondylitis and axial psoriatic arthritis are part of a spectrum of the same disease, or whether they are separate diseases with overlapping features.

Systemic Lupus Erythematosus Managing Cognitive Dysfunction in Systemic Lupus Erythematosus

Managing Cognitive Dysfunction in Systemic Lupus Erythematosus

The pathogenic pathways of SLE-related cognitive dysfunction are yet to be fully elucidated, but vasculopathy, antibody-mediated neurotoxicity, impairments in cytokine signaling, and complement abnormalities have been proposed as contributing factors.

Sign Up for Free e-newsletters